Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
29.45
-0.15 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
29.15
-0.30 (-1.02%)
After-hours: Dec 5, 2025, 5:58 PM EST
Celldex Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,957 | 1,677 | 2,169 | 2,099 | 1,803 | 693 | |
| Market Cap Growth | 18.08% | -22.71% | 3.32% | 16.42% | 160.10% | 1759.97% | |
| Enterprise Value | 1,376 | 924 | 1,936 | 1,779 | 1,383 | 497 | |
| Last Close Price | 29.45 | 25.27 | 39.66 | 44.57 | 38.64 | 17.52 | |
| PS Ratio | 752.96 | 238.82 | 315.12 | 890.64 | 387.68 | 93.45 | |
| PB Ratio | 3.27 | 2.24 | 5.05 | 6.44 | 4.30 | 3.31 | |
| P/TBV Ratio | 3.43 | 2.33 | 5.40 | 7.02 | 4.60 | 3.88 | |
| EV/Sales Ratio | 529.56 | 131.57 | 281.34 | 754.94 | 297.37 | 67.06 | |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Asset Turnover | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 | |
| Quick Ratio | 12.55 | 18.38 | 13.69 | 16.41 | 24.71 | 13.81 | |
| Current Ratio | 13.01 | 18.92 | 13.87 | 17.07 | 24.86 | 13.93 | |
| Return on Equity (ROE) | -32.44% | -26.84% | -37.45% | -30.13% | -22.43% | -39.41% | |
| Return on Assets (ROA) | -21.77% | -19.38% | -21.70% | -16.79% | -12.70% | -17.27% | |
| Return on Capital (ROIC) | -23.04% | -20.62% | -23.30% | -17.78% | -13.60% | -19.96% | |
| Return on Capital Employed (ROCE) | -42.60% | -25.90% | -32.70% | -32.10% | -16.20% | -22.40% | |
| Earnings Yield | -11.47% | -9.42% | -6.52% | -5.35% | -3.91% | -8.62% | |
| FCF Yield | -9.28% | -9.53% | -5.03% | -5.03% | -3.45% | -6.05% | |
| Buyback Yield / Dilution | -9.16% | -32.91% | -3.33% | -9.37% | -44.64% | -104.31% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.